These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 28178642)
1. P21-activated kinase 4 involves TSH induced papillary thyroid cancer cell proliferation. Xie X; Shi X; Guan H; Guo Q; Fan C; Dong W; Wang G; Li F; Shan Z; Cao L; Teng W Oncotarget; 2017 Apr; 8(15):24882-24891. PubMed ID: 28178642 [TBL] [Abstract][Full Text] [Related]
2. [Correlation between thyroid-stimulating hormone-peroxiredoxin1 signaling pathway and invasion of papillary thyroid carcinoma]. Liu X; Gao M Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Apr; 44(4):287-91. PubMed ID: 19558833 [TBL] [Abstract][Full Text] [Related]
3. Identification of Jiang YJ; Xia Y; Hu YX; Han ZJ; Guo AY; Huang T Thyroid; 2024 May; 34(5):583-597. PubMed ID: 38411500 [No Abstract] [Full Text] [Related]
4. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling. He LF; Xu HW; Chen M; Xian ZR; Wen XF; Chen MN; Du CW; Huang WH; Wu JD; Zhang GJ Oncotarget; 2017 Mar; 8(11):17573-17585. PubMed ID: 28407679 [TBL] [Abstract][Full Text] [Related]
5. Different growth control of the two human thyroid cell lines of adenomatous goiter and papillary carcinoma. Hishinuma A; Yamanaka T; Kasai K; So S; Tseng CC; Bamba N; Ohtake H; Shimoda S Thyroid; 1995 Feb; 5(1):41-6. PubMed ID: 7787432 [TBL] [Abstract][Full Text] [Related]
6. BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor. Zheng H; Wang M; Jiang L; Chu H; Hu J; Ning J; Li B; Wang D; Xu J Cancer Res Treat; 2016 Apr; 48(2):698-707. PubMed ID: 26323637 [TBL] [Abstract][Full Text] [Related]
7. Desensitization of cyclic adenosine 3,5'-monophosphate response to thyrotropin in normal and primary or metastatic papillary thyroid cancer cells in vitro. Tezelman S; Siperstein AE; Duh QY; Wong MG; Clark OH Surgery; 1996 Dec; 120(6):926-33. PubMed ID: 8957475 [TBL] [Abstract][Full Text] [Related]
8. p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion. Lu W; Xia YH; Qu JJ; He YY; Li BL; Lu C; Luo X; Wan XP Neoplasma; 2013; 60(5):493-503. PubMed ID: 23790167 [TBL] [Abstract][Full Text] [Related]
9. Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro: evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors. Hoffmann S; Hofbauer LC; Scharrenbach V; Wunderlich A; Hassan I; Lingelbach S; Zielke A J Clin Endocrinol Metab; 2004 Dec; 89(12):6139-45. PubMed ID: 15579770 [TBL] [Abstract][Full Text] [Related]
10. Role of Epac and protein kinase A in thyrotropin-induced gene expression in primary thyrocytes. van Staveren WC; Beeckman S; Tomás G; Dom G; Hébrant A; Delys L; Vliem MJ; Trésallet C; Andry G; Franc B; Libert F; Dumont JE; Maenhaut C Exp Cell Res; 2012 Mar; 318(5):444-52. PubMed ID: 22240166 [TBL] [Abstract][Full Text] [Related]
11. p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation. Siu MK; Kong DS; Ngai SY; Chan HY; Jiang L; Wong ES; Liu SS; Chan KK; Ngan HY; Cheung AN PLoS One; 2015; 10(7):e0133467. PubMed ID: 26218748 [TBL] [Abstract][Full Text] [Related]
12. p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients. Siu MK; Chan HY; Kong DS; Wong ES; Wong OG; Ngan HY; Tam KF; Zhang H; Li Z; Chan QK; Tsao SW; Strömblad S; Cheung AN Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18622-7. PubMed ID: 20926745 [TBL] [Abstract][Full Text] [Related]
13. LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells. Zhang J; Wang J; Guo Q; Wang Y; Zhou Y; Peng H; Cheng M; Zhao D; Li F Cancer Lett; 2012 Apr; 317(1):24-32. PubMed ID: 22085492 [TBL] [Abstract][Full Text] [Related]
14. p21-Activated kinase 4 promotes prostate cancer progression through CREB. Park MH; Lee HS; Lee CS; You ST; Kim DJ; Park BH; Kang MJ; Heo WD; Shin EY; Schwartz MA; Kim EG Oncogene; 2013 May; 32(19):2475-82. PubMed ID: 22710715 [TBL] [Abstract][Full Text] [Related]
15. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition. Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion. Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262 [TBL] [Abstract][Full Text] [Related]
17. USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma. Jia M; Guo Y; Lu X Cell Physiol Biochem; 2018; 45(5):2044-2053. PubMed ID: 29533940 [TBL] [Abstract][Full Text] [Related]
18. CHK2 Promotes Anoikis and is Associated with the Progression of Papillary Thyroid Cancer. Zhao W; Chen S; Hou X; Chen G; Zhao Y Cell Physiol Biochem; 2018; 45(4):1590-1602. PubMed ID: 29486482 [TBL] [Abstract][Full Text] [Related]
19. The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals. De Gregorio G; Coppa A; Cosentino C; Ucci S; Messina S; Nicolussi A; D'Inzeo S; Di Pardo A; Avvedimento EV; Porcellini A Oncogene; 2007 Mar; 26(14):2039-47. PubMed ID: 17043656 [TBL] [Abstract][Full Text] [Related]
20. p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and β-catenin/MITF pathways. Yun CY; You ST; Kim JH; Chung JH; Han SB; Shin EY; Kim EG J Invest Dermatol; 2015 May; 135(5):1385-1394. PubMed ID: 25560280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]